Patents by Inventor David Lee Farb

David Lee Farb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions of a HER2/neu Antibody and Use of the Same
    Publication number: 20230053747
    Abstract: The present invention is directed in part to pharmaceutical compositions for storage and administration comprising a) a HER2/neu antibody (“margetuximab”), b) buffering agents, and c) stabilizers, wherein said margetuximab is stable. The invention in part provides, containers and kits comprising such pharmaceutical compositions. The invention is directed in part to the use of such pharmaceutical compositions, containers, and kits containing margetuximab in the treatment of HER2/neu-positive cancer (i.e., a cancer that expresses HER2), including breast cancer or gastric cancer or GEJ cancer.
    Type: Application
    Filed: August 24, 2022
    Publication date: February 23, 2023
    Applicant: MacroGenics, Inc,
    Inventors: David Lee Farb, Yan Zhou, Krishnan Sampathkumar
  • Pharmaceutical compositions of a HER2/neu antibody and use of the same
    Patent number: 11459399
    Abstract: The present invention is directed in part to pharmaceutical compositions for storage and administration comprising a) a HER2/neu antibody (“margetuximab”), b) buffering agents, and c) stabilizers, wherein said margetuximab is stable. The invention in part provides, containers and kits comprising such pharmaceutical compositions. The invention is directed in part to the use of such pharmaceutical compositions, containers, and kits containing margetuximab in the treatment of HER2/neu-positive cancer (i.e., a cancer that expresses HER2), including breast cancer or gastric cancer or GEJ cancer.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: October 4, 2022
    Assignee: MacroGenics, Inc.
    Inventors: David Lee Farb, Yan Zhou, Krishnan Sampathkumar
  • Pharmaceutical Compositions of a HER2/neu Antibody and Use of the Same
    Publication number: 20220177602
    Abstract: The present invention is directed in part to pharmaceutical compositions for storage and administration comprising a) a HER2/neu antibody (“margetuximab”), b) buffering agents, and c) stabilizers, wherein said margetuximab is stable. The invention in part provides, containers and kits comprising such pharmaceutical compositions. The invention is directed in part to the use of such pharmaceutical compositions, containers, and kits containing margetuximab in the treatment of HER2/neu-positive cancer (i.e., a cancer that expresses HER2), including breast cancer or gastric cancer or GEJ cancer.
    Type: Application
    Filed: December 3, 2021
    Publication date: June 9, 2022
    Applicant: MacroGenics, Inc.
    Inventors: David Lee Farb, Yan Zhou, Krishnan Sampathkumar